1 / 6

Everotas 5mg | Everolimus |Blueberry pharmaceuticals

Everotas 5 mg belongs to anti-neoplastic agent; it comes under mTOR kinase inhibitor (single transduction inhibitor).Everotas 5mg is an immunosuppressive macrolide @ Blueberry pharmaceuticals

RobbieRoyce
Download Presentation

Everotas 5mg | Everolimus |Blueberry pharmaceuticals

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. BLUEBERRYPHARMACEUTICALS We will not dispense any prescription medication without a valid prescription from a licensed physician.

  2. EVEROLIMUS Everotas 5mg

  3. DESCRIPTION • USED FOR • Breast cancer  • patient who fails to respond to the tablet letrozole or anastrozole therapy would be treated with Everotas. Everotas 5mg is used in an advanced stage of breast cancer.  • Neuroendocrine tumors  • Everotas 5mg involved in the treatment of some neuroendocrine tumors like pancreatic, gastrointestinal or lung cancer.  Everotas 5mg belongs to anti-neoplastic agent, it comes under mTOR kinase inhibitor (single transduction inhibitor). Everotas 5mg is an immunosuppressive macrolide.

  4. MECHANISM • DOSAGE • The recommended dose of the Tablet Everotas is 10mg should be taken as a single dose in all carcinogenic condition, except organ transplantation. • Organ transplant: 0.75mg orally twice daily. • Brain/intracranial tumor: 4.5mg/m2 orally once a day (for both pediatric and adult dose) • Hepatic impairment: dose reduced to 7.5mg once daily followed by 5mg as a single dose. Everotas is the prohibition of mammalian target of rapamycin (mTOR), a serine-threonine kinase. Everotasbind with intercellular protein (FKBP-12), leads to inhibitory complex formation with mTOR complex 1 (mTORC1) this leads to inhibition of mTOR kinase activity.

  5. PREGNANCY • Everotas 5mg should not use in pregnancy conditions and for breastfeeding mothers. Pregnancy category: C Everotas5mg causes harm or any malformation in unborn babies. • STORAGE • Everotas 5mg should be stored in room temperature • Keep away from moisture, heat, and light

  6. CALL CONTACT US • +91-97890 77748 MAIL VISIT US • info@blueberrypharma.com • https://blueberrypharma.com/ ADDRESS NEW NO. 3, Old No. 19, Cauvery Nagar 2nd Street, Kodungaiyur, chennai- 600 118.

More Related